DARA WOTHERSPOON: Open Payments
NPI 1588079735 · SPOTSYLVANIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,753 in 67 payments from 14 companies in 2025. Trend: 2023 $1,655 · 2024 $1,767 · 2025 $1,753
Food & beverage: $1,753
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 16 | $329 |
| AstraZeneca Pharmaceuticals LP | 8 | $287 |
| ABBVIE INC. | 11 | $279 |
| Novo Nordisk Inc | 5 | $129 |
| Lilly USA, LLC | 9 | $127 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $115 |
| Janssen Biotech, Inc. | 1 | $114 |
| Abbott Laboratories | 4 | $90 |
| Exact Sciences Corporation | 3 | $67 |
| Astellas Pharma US Inc | 2 | $59 |
Products named: AIRSUPRA, NURTEC ODT, NEFFY, TREMFYA, Ozempic, FREESTYLE LIBRE 3, QULIPTA, PAXLOVID.
Industry payments across VA — which companies pay providers there.
